Recalls / Active ingredient / Pazopanib Hydrochloride
Pazopanib Hydrochloride
1 FDA drug recall involving the active ingredient “Pazopanib Hydrochloride”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2023-11-20 | Class III | Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbe | Siegfried Barbera, SL |